Literature DB >> 10082401

Histopathology of an adverse reaction to a eutectic mixture of the local anesthetics lidocaine and prilocaine.

D M Hoss1, E G Gross, J M Grant-Kels.   

Abstract

A unique histopathologic reaction to the topical application of a eutectic mixture of the local anesthetics lidocaine and prilocaine (EMLA), used for topical anesthesia prior to biopsy in two children is described. Standard application of EMLA cream under occlusion for 1 h was given to both patients. The biopsies in both cases demonstrate focal vacuolization of the upper spinous and granular layers. The epidermis was focally separated from the dermis in areas of basal vacuolar alteration. Electron microscopy performed in one case demonstrated the dermal-epidermal cleft to be secondary to alteration of the basal cells with condensation of the cytoplasm and cytologic degeneration similar to that seen in epidermolysis bullosa simplex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082401     DOI: 10.1111/j.1600-0560.1999.tb01810.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Pseudo-lysosomal storage disease caused by EMLA cream.

Authors:  H Vallance; T Chaba; L Clarke; G Taylor
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Music-based interventions for pain relief in patients undergoing hemodialysis: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Jingru Cheng; Hui Zhang; Hong Bao; Hanxia Hong
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

3.  Effectiveness of music therapy for alleviating pain during haemodialysis access cannulation for patients undergoing haemodialysis: a multi-facility, single-blind, randomised controlled trial.

Authors:  Masatsugu Kishida; Yosuke Yamada; Emi Inayama; Mineaki Kitamura; Tomoya Nishino; Keiko Ota; Ayumi Shintani; Tatsuyoshi Ikenoue
Journal:  Trials       Date:  2019-11-19       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.